Exponent Inc
(FRA:EP5)
€
57.7
+0.48 (+0.84%)
Market Cap: 2.81 Bil
Enterprise Value: 2.82 Bil
PE Ratio: 29.94
PB Ratio: 11.22
GF Score: 76/100 
Q2 2026 Exponent Inc Earnings Call Transcript
Jul 30, 2026 / 08:30PM GMT
Release Date Price:
€55.3
(-3.15%)
Key Points
Positve
- Exponent Inc (EXPO) delivered strong double-digit growth in revenues and earnings in Q2 2026, with total revenues up 21% and net revenues up 12% year-over-year.
- The company is benefiting from powerful long-term trends, including accelerating AI integration into physical products, which is driving demand for its specialized user research and human-machine interaction expertise.
- Proactive work saw strong growth, led by demand for user research studies and increased risk management and infrastructure-related engagements in the utility sector.
- Reactive work also grew, with strong demand for dispute-related expertise from the consumer products, chemicals, and transportation industries, including failure analysis for advanced driver assistance systems.
- The company raised its full-year 2026 guidance, now expecting net revenues to grow 9% to 10% and EBITDA margin to be 27.8% to 28.1% of net revenues.
- Exponent Inc (EXPO) continues to return significant capital to shareholders, repurchasing $67.4 million of stock in Q2 and increasing its repurchase program by $50 million, reflecting confidence in long-term growth.
- Utilization improved to 74% in Q2, up from 72% in the same period last year, and the company realized a 4% rate increase, indicating strong pricing power.
- The company's multidisciplinary expertise and long-standing reputation in failure analysis uniquely position it to handle complex, novel challenges, such as a recent satellite performance issue engagement.
- The company is successfully attracting top-tier PhD talent despite a tightening supply, leveraging its value proposition of working on real-world, high-impact problems.
- The user research practice is diversifying across more clients, industries, and technologies, including health-related wearables and FDA-regulated medical devices, expanding its market opportunity.
Negative
- Exponent Inc (EXPO)'s Q2 results were partially boosted by a large user research study that represented 4% of net revenues, higher than the expected 2%, and this study is expected to moderate to 2% of net revenues for the remainder of the year, creating a tough comparison.
- The company's full-year utilization guidance of 72.5% to 73% appears conservative relative to the strong Q2 utilization of 74%, potentially signaling a slowdown in demand or seasonality headwinds in Q4.
- G&A expenses increased 20% in Q2 due to higher travel, meals, recruiting, and relocation costs, which could pressure margins if not managed carefully.
- Interest income decreased to $716,000 in Q2 due to lower cash balances, a trend expected to continue as the company has reduced its cash reserves through aggressive share repurchases.
- The company faces potential talent supply risks as the number of PhD graduates in the US is declining, which could make it harder to recruit top-tier scientific talent in the future.
- The tax rate is expected to increase to 28.5% for the full year 2026, up from 28.0% in 2025, which could slightly dampen net income growth.
- The company's heavy reliance on reimbursable expenses, which drove total revenue growth faster than net revenue growth, can cause volatility in reported revenue figures.
- While the company is confident in its growth trajectory, the pace of share repurchases is expected to slow in the second half of the year due to lower cash levels, potentially reducing the tailwind to EPS growth.
- The company's proactive work is concentrated in a few key verticals, such as consumer electronics, chemicals, and utilities, which could expose it to sector-specific downturns.
- The increasing complexity and scope of user research studies, while a competitive advantage, also require significant investment in hiring and infrastructure, which could pressure near-term margins.
Operator
Good day, and welcome to the Exponent Inc. second quarter 2026 earnings conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After todayâs presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on a touch-tone phone. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Joni Konstantelos, managing director. Please go ahead.
Joni Konstantelos
Thank you, operator. Good afternoon, ladies and gentlemen. Thank you for joining us on Exponentâs second quarter 2026 financial results conference call. Please note that this call will be simultaneously webcast on the investor relations section of the companyâs corporate website at www.investors.exponent.com.
This conference call is the property of Exponent, any taping or other
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers